Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

Shelley Wood

September 20, 2021

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

Presentation AVIC 2020

Caso En Vivo 4: Lotus Edge

Presenter: César Morís

January 31, 2020

Presentation TCT Abstracts Posters 2019

Budget Impact of Mechanically Expanded Versus Self-Expanding Transcatheter Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis: A Medicare Perspective

Presenter: Stacey Amorosi

October 15, 2019

Presentation TVT 2019

The LOTUS Edge TAVR System: Clinical Trial Updates

Presenter: Chris Meduri

June 13, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

News Daily News

Lotus Valve’s Return to Market in Europe Sees Further Delays

Shelley Wood

November 29, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

The LOTUS TAVR System: A Cool Case, New Technology (Including EDGE), and Clinical Program Updates

Presenter: Michael J. Reardon

June 16, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

Presentation JIM 2017

My Evolving Clinical Experience: From Lotus to Edge

Presenter: Giuseppe Tarantini

February 24, 2017

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

Advertisement

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Which TAVR Device Is Best? Review Tackles Optimal Selection

Caso En Vivo 4: Lotus Edge

Budget Impact of Mechanically Expanded Versus Self-Expanding Transcatheter Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis: A Medicare Perspective

The LOTUS Edge TAVR System: Clinical Trial Updates

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Lotus Valve’s Return to Market in Europe Sees Further Delays

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

The LOTUS TAVR System: A Cool Case, New Technology (Including EDGE), and Clinical Program Updates

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

My Evolving Clinical Experience: From Lotus to Edge

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content